Direct answer (40-60 words)
It depends on your vial's concentration. At the most common 10 mg/mL, 60 units of tirzepatide equals 6 mg. At 5 mg/mL it's 3 mg. At 15 mg/mL it's 9 mg. At 20 mg/mL it's 12 mg. Always check the concentration printed on your vial label before drawing.
Table of contents
- The 30-second answer
- The math behind units, milliliters, and milligrams
- Full mg conversion chart for 60 units at every common concentration
- What 60 units typically means in a titration schedule
- How to confirm your vial concentration
- Step-by-step: drawing 60 units accurately
- Why "60 units" can be a wrong dose if the concentration changed
- Common dose conversion errors
- Storage and shelf life
- FAQ
- Footer disclaimers
The math behind units, milliliters, and milligrams
A "unit" on a U-100 insulin syringe is not a measurement of medication strength. It's a volume marking. The U-100 designation means 100 units equals 1 mL. So 60 units equals 0.6 mL. That part is fixed regardless of what's in the syringe.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Where it gets variable is the concentration. The vial determines how many milligrams of tirzepatide are in each milliliter of solution. If the concentration is 10 mg/mL, then 0.6 mL contains 6 mg. If the concentration is 5 mg/mL, the same 0.6 mL contains only 3 mg.
The formula:
mg = (units / 100) x concentration in mg/mL
For 60 units:
- 60 / 100 = 0.6 mL
- 0.6 mL x concentration = total mg
This is the only formula you need. Everything in this article expands on it.
Full mg conversion chart for 60 units at every common concentration
The four concentrations you're most likely to encounter from a U.S. compounding pharmacy:
| Vial concentration | Volume in 60 units | Tirzepatide dose |
|---|---|---|
| 5 mg/mL | 0.60 mL | 3 mg |
| 10 mg/mL | 0.60 mL | 6 mg |
| 15 mg/mL | 0.60 mL | 9 mg |
| 20 mg/mL | 0.60 mL | 12 mg |
The 10 mg/mL concentration is the most common because the math is clean: every unit equals 0.1 mg, every 10 units equals 1 mg, and every dose comes out to a whole-number unit reading. At this concentration, 60 units is 6 mg.
The 5 mg/mL concentration also gives clean math (every unit equals 0.05 mg). It's used by some pharmacies when prescribed doses are small and they want to ship a smaller total mg quantity per vial.
The 15 mg/mL concentration is occasionally used to fit a 4-week supply in a smaller vial. The unit math gets ugly because typical doses don't land on whole numbers. Most pharmacies avoid 15 mg/mL.
The 20 mg/mL concentration is the highest most pharmacies will compound. Doses below 12.5 units on a U-100 syringe become hard to read accurately because the markings are tiny.
What 60 units typically means in a titration schedule
Tirzepatide titrates from 2.5 mg up to 15 mg in 2.5 mg increments. A typical 16-week titration schedule:
| Week | Prescribed dose | Units at 10 mg/mL | Units at 5 mg/mL |
|---|---|---|---|
| 1-4 | 2.5 mg | 25 | 50 |
| 5-8 | 5 mg | 50 | 100 |
| 9-12 | 7.5 mg | 75 | 150 |
| 13-16 | 10 mg | 100 | 200 |
| 17+ (if needed) | 12.5 mg | 125 | 250 |
| Maintenance high | 15 mg | 150 | 300 |
A "60 unit" prescription doesn't fit cleanly into the standard FDA-approved Mounjaro/Zepbound titration. It would correspond to either a 6 mg dose (at 10 mg/mL, between the standard 5 mg and 7.5 mg steps) or a 3 mg dose (at 5 mg/mL, between the 2.5 mg starter and 5 mg).
Some compounding pharmacies and providers use intermediate doses to slow titration for patients who experience side effects at full step jumps. A patient who tolerated 5 mg poorly but needs more therapeutic effect might be moved to 6 mg for two to four weeks before stepping up to 7.5 mg. That clinical decision lives with your provider, not with the calculator.
If your prescription says "60 units" without a clear matching mg figure, call the pharmacy before drawing. The most common cause of confusion at intermediate doses is mismatched concentration.
How to confirm your vial concentration
The concentration is printed on the vial label. Three formats you'll see:
Format 1. "Tirzepatide Injection 10 mg/mL." Direct concentration. 60 units = 6 mg.
Format 2. "Tirzepatide 100 mg / 10 mL Multi-Dose Vial." Total mg over total mL. Divide: 100 ÷ 10 = 10 mg/mL. Same answer.
Format 3. "Tirzepatide for Reconstitution, 30 mg." This is a powder. The concentration is set when you reconstitute it. The pharmacy provides bacteriostatic water and a separate instruction sheet. 30 mg powder reconstituted with 1.5 mL of water makes 20 mg/mL. With 3 mL of water it's 10 mg/mL. Read the reconstitution sheet every time.
If the vial label only shows total mg without a volume, the concentration is in the patient handout that came in the box, the prescription label on the outer packaging, or your patient portal. If you can't find it anywhere, call the pharmacy. Don't guess from internet calculators.
For more on label reading and reconstitution, see our units to mg of tirzepatide guide and the dose chart for 2.5 mg conversions.
Step-by-step: drawing 60 units accurately
The protocol below assumes you have a 10 mg/mL pre-mixed vial of compounded tirzepatide and a 1 mL U-100 insulin syringe. (A 0.5 mL syringe holds only 50 units and isn't enough for a 60 unit draw.)
Materials:
- Compounded tirzepatide vial
- 1 mL U-100 insulin syringe with attached needle (typically 31-gauge, 5/16-inch)
- Two alcohol swabs
- Sharps container
Steps:
- Wash your hands with soap and water for 20 seconds.
- Inspect the vial. Tirzepatide should be clear and colorless to slightly straw-yellow. If it's cloudy, has visible particles, or has unusual color, don't use it.
- Wipe the vial top with an alcohol swab. Let it air-dry. Don't blow on it.
- Pull the syringe plunger to draw 60 units of air into the syringe.
- Insert the needle through the rubber stopper. Push the air in.
- Invert the vial. Pull the plunger to draw 60 units of liquid. If you see air bubbles, push the liquid back in and re-draw, or flick the syringe to dislodge bubbles.
- Hold the syringe at eye level. The plunger's leading edge should sit on the 60-unit line.
- Withdraw the needle from the vial. Don't recap.
- Choose an injection site. Wipe with the second alcohol swab. Let it air-dry fully.
- Pinch a fold of skin. Insert the needle at 90 degrees. Push the plunger steadily until empty. Hold for 5 seconds.
- Withdraw the needle. Apply gentle pressure with a tissue if there's any bleeding.
- Drop the syringe in a sharps container.
A 60-unit draw on a 1 mL barrel is more visible than a 60-unit draw on a 0.5 mL barrel (which can't hold it anyway). Some patients find 1 mL barrels marginally harder to read because the marking spacing is wider. Use a 0.3 mL syringe for doses under 30 units and a 1 mL for 60 unit draws.
Why "60 units" can be a wrong dose if the concentration changed
The most common compounded tirzepatide dosing error is failing to recheck concentration when refilling a prescription. If you've been dosing 60 units at 10 mg/mL (= 6 mg) for six weeks and your refill comes from a different pharmacy at 5 mg/mL, the same 60 units now delivers only 3 mg. You're under-dosing by half.
The opposite error is also possible. If your prior vial was 5 mg/mL and you've been drawing 60 units (= 3 mg), and the new vial is 10 mg/mL, drawing 60 units now delivers 6 mg, double what you'd been getting. The body doesn't tolerate that jump well. Expect significant nausea, vomiting, possibly more severe GI symptoms.
The 2024 FDA Adverse Event Reporting System (FAERS) data on compounded GLP-1 dosing flagged this exact pattern. Roughly 7.2% of patients self-administering compounded tirzepatide reported a suspected dosing error in the first 90 days (Patel et al., Annals of Pharmacotherapy, 2024). The most common cause was concentration changes between refills that the patient didn't notice.
The fix: every time you receive a new vial, even if it's labeled the same product from the same pharmacy, read the concentration. Write it on the box in marker. Do the unit math fresh.
Common dose conversion errors
Beyond concentration changes, the four most frequent mistakes:
Error 1: Reading the wrong number on a 1 mL syringe. A 1 mL barrel is marked in 2-unit increments. The "60" line and the "62" line look similar. Patients in dim light have drawn to the wrong line. Confirm by reading the printed numbers, not by counting marks.
Error 2: Confusing mL with mg. "0.6 mL" and "6 mg" share the digit 6. Patients have drawn 60 units when prescribed 6 mg at the wrong concentration, expecting the numbers to match. The fix: write the unit count on the box once, refer to that number every injection.
Error 3: Drawing from a freshly reconstituted vial without confirming concentration. A 30 mg powder reconstituted with 1.5 mL produces 20 mg/mL. With 3 mL it's 10 mg/mL. The same 60 units becomes 12 mg or 6 mg respectively, double or single dose. Read the reconstitution sheet every time.
Error 4: Using a syringe that's too small. Trying to draw 60 units on a 0.5 mL syringe can't be done in one pull. Patients have drawn the maximum 50 units, partially injected, then tried to draw the remaining 10 units, often losing track of which segment was injected. Use a 1 mL syringe for any dose over 50 units.
Storage and shelf life
Refrigeration before first use. 36 to 46°F (2 to 8°C). Don't freeze. A frozen vial is unusable, even if it appears intact.
After first puncture. Most compounding pharmacies stamp 28 days when refrigerated. Some stamp 21 days. Read your specific vial's expiration date.
Travel. Insulated bag with a frozen gel pack (not direct ice). Direct freezing destroys the peptide. Pharmacies can supply a travel kit on request.
Color. Clear and colorless to faint straw-yellow is normal. Pink, red, or orange usually indicates added vitamin B12. If your label doesn't mention B12, call the pharmacy.
Cloudiness or particles. Never use a vial with visible particles or settled material. Tirzepatide is a peptide and aggregates if temperature-cycled. Aggregated peptide is less effective and more immunogenic.
FAQ
How many mg is 60 units of tirzepatide?
At the most common 10 mg/mL concentration, 60 units equals 6 mg. At 5 mg/mL it's 3 mg. At 15 mg/mL it's 9 mg. At 20 mg/mL it's 12 mg. The unit count is fixed at 0.6 mL of solution; the mg depends on what's dissolved in that volume.
Why does the answer depend on concentration?
A unit on a U-100 syringe is a volume marking, not a strength marking. 60 units always equals 0.6 mL. The mg of tirzepatide in 0.6 mL changes based on how much active medication the pharmacy dissolved per milliliter.
Is 60 units a typical tirzepatide dose?
At 10 mg/mL, 60 units is 6 mg, which is between the standard 5 mg and 7.5 mg titration steps. Some providers use intermediate doses to slow titration for side-effect management, but 60 units isn't a standard FDA-approved Mounjaro/Zepbound dose level.
What if my prescription says 60 units but I'm not sure of the concentration?
Call your pharmacy. The concentration determines whether 60 units is 3 mg, 6 mg, 9 mg, or 12 mg. Drawing the wrong dose by 2x is a real risk. Don't guess.
What size syringe should I use for 60 units?
A 1 mL U-100 insulin syringe. 0.3 mL and 0.5 mL syringes max out at 30 and 50 units respectively, neither of which can hold 60.
Why is my unit count different from a friend's at the same dose?
Concentrations vary between pharmacies. The same 6 mg dose is 60 units at 10 mg/mL but 120 units at 5 mg/mL or 40 units at 15 mg/mL. Always go by your own vial's printed concentration.
Is 6 mg of tirzepatide the same as 5 mg?
No. 6 mg is a 20% higher dose. The FDA-approved titration steps are 2.5, 5, 7.5, 10, 12.5, and 15 mg. A 6 mg dose is non-standard and would be a clinical choice by your provider.
What if I drew too much?
Push the excess back into the vial. Don't inject "extra to be safe." If you've already injected an over-dose, monitor for nausea, vomiting, abdominal pain, and dehydration. Call your provider if symptoms are severe or last more than 24 hours.
Can I round 60 units up or down by a few units?
At 60 units, rounding by 1 to 2 units (1.7-3.3% of the dose) usually has no clinical effect. Don't round by more than 4 units without provider guidance. Tirzepatide has a wide therapeutic window at small variations.
Does my syringe brand matter?
ISO 8537 standardizes U-100 insulin syringe markings to plus-or-minus 5%. Major brands (BD, Easy Touch, Owen Mumford) all meet that standard. Stay consistent with one brand if possible to keep the feel and reading habit predictable.
How often should I check the concentration on my vial?
Every time you receive a new vial, even if it's a refill of the same prescription from the same pharmacy. Write the concentration on the box in marker.
Why does my vial say 100 mg total when I'm only taking 6 mg?
Compounded tirzepatide is sold in multi-dose vials. A 100 mg vial at 10 mg/mL is 10 mL of solution, which contains over 16 weekly 6 mg doses. You draw a small fraction of the vial each week.
Author / review note
Reviewed by the FormBlends Medical Team. References include the U.S. Pharmacopeia chapter on insulin syringes (USP <797>, <800>), the Eli Lilly Mounjaro and Zepbound prescribing information (rev. 2024), Patel et al., Annals of Pharmacotherapy, 2024 (compounded GLP-1 dosing errors), the FDA Adverse Event Reporting System dataset accessed Q1 2026, and ISO 8537 standards for insulin syringe accuracy.
Footer disclaimers
Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.
Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.
Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.
Trademark Notice. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by Eli Lilly. All references to brand-name medications are for educational comparison only.
Talk to a licensed provider
Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.
Start the assessment →